JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Improves Hyperglycemia and Dyslipidemia Independent of Suppression of Food Intake in Diabetic Rats

Figure 2

Changes in blood glucose (a), insulin (b), triglyceride (c), total cholesterol (d), and free fatty acid (e) levels in control group, JTT-130 treatment group, and pair-fed group. Data represent mean values ± s.d. (𝑛=5-6). ^∗𝑃<0.05, ^∗∗𝑃<0.01: significantly different from control group. ^#𝑃<0.05, ^##𝑃<0.01: significantly different from pair-fed group.

(a)

(b)

(c)

(d)

(e)